Sintx Technologies (SINT) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -75.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.27% |
| Dec 31, 2025 | 63.21% |
| Sep 30, 2025 | 52.38% |
| Jun 30, 2025 | 55.26% |
| Mar 31, 2025 | 51.79% |
| Dec 31, 2024 | 27.34% |
| Sep 30, 2024 | -326.05% |
| Jun 30, 2024 | -238.48% |
| Mar 31, 2024 | -353.51% |
| Dec 31, 2023 | -1,000.55% |
| Sep 30, 2023 | -1,012.87% |
| Jun 30, 2023 | -603.60% |
| Mar 31, 2023 | 54.16% |
| Dec 31, 2022 | -193.65% |
| Sep 30, 2022 | -135.85% |
| Jun 30, 2022 | -45.33% |
| Mar 31, 2022 | -72.56% |
| Dec 31, 2021 | -12.32% |
| Sep 30, 2021 | 76.67% |
| Jun 30, 2021 | 87.79% |
| Mar 31, 2021 | 52.09% |
| Dec 31, 2020 | 27.00% |
| Sep 30, 2020 | 45.51% |
| Jun 30, 2020 | 14.50% |
| Mar 31, 2020 | -95.74% |
| Dec 31, 2019 | -41.89% |
| Sep 30, 2019 | 47.99% |
| Jun 30, 2019 | 11.41% |
| Mar 31, 2019 | 14.86% |
| Dec 31, 2018 | -64.08% |
| Sep 30, 2018 | 35.63% |
| Jun 30, 2018 | -211.31% |
| Mar 31, 2018 | 30.66% |
| Dec 31, 2017 | 64.70% |
| Sep 30, 2017 | -20.36% |
| Jun 30, 2017 | 19.41% |
| Mar 31, 2017 | 38.92% |
| Dec 31, 2016 | -9.33% |
| Sep 30, 2016 | -13.25% |
| Jun 30, 2016 | 6.10% |
| Mar 31, 2016 | 24.55% |